These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 1718753

  • 1. Recombinant aprotinin homologue with new inhibitory specificity for cathepsin G.
    Brinkmann T, Schnierer S, Tschesche H.
    Eur J Biochem; 1991 Nov 15; 202(1):95-9. PubMed ID: 1718753
    [Abstract] [Full Text] [Related]

  • 2. Design of an aprotinin variant with inhibitory activity against chymotrypsin and cathepsin G by recombinant DNA technology.
    Brinkmann T, Tschesche H.
    Biol Chem Hoppe Seyler; 1990 May 15; 371 Suppl():43-52. PubMed ID: 1698068
    [Abstract] [Full Text] [Related]

  • 3. Replacement of lysine by arginine, phenylalanine and tryptophan in the reactive site of the bovine trypsin-kallikrein inhibitor (Kunitz) and change of the inhibitory properties.
    Jering H, Tschesche H.
    Eur J Biochem; 1976 Jan 15; 61(2):453-63. PubMed ID: 129327
    [Abstract] [Full Text] [Related]

  • 4. Specificity of human cathepsin G.
    Polanowska J, Krokoszynska I, Czapinska H, Watorek W, Dadlez M, Otlewski J.
    Biochim Biophys Acta; 1998 Jul 28; 1386(1):189-98. PubMed ID: 9675278
    [Abstract] [Full Text] [Related]

  • 5. Expression, isolation and characterization of recombinant [Arg15,Glu52]aprotinin.
    Auerswald EA, Hörlein D, Reinhardt G, Schröder W, Schnabel E.
    Biol Chem Hoppe Seyler; 1988 May 28; 369 Suppl():27-35. PubMed ID: 2462433
    [Abstract] [Full Text] [Related]

  • 6. Inhibitory properties of separate recombinant Kunitz-type-protease-inhibitor domains from tissue-factor-pathway inhibitor.
    Petersen LC, Bjørn SE, Olsen OH, Nordfang O, Norris F, Norris K.
    Eur J Biochem; 1996 Jan 15; 235(1-2):310-6. PubMed ID: 8631347
    [Abstract] [Full Text] [Related]

  • 7. Biotinylated aprotinin: a versatile probe for the detection of serine proteinases on western blots.
    Melrose J, Ghosh P, Patel M.
    Int J Biochem Cell Biol; 1995 Sep 15; 27(9):891-904. PubMed ID: 7584624
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of tryptase TL2 from human T4+ lymphocytes and inhibition of HIV-1 replication in H9 cells by recombinant aprotinin and bikunin homologues.
    Brinkmann T, Schäfers J, Gürtler L, Kido H, Niwa Y, Katunuma N, Tschesche H.
    J Protein Chem; 1997 Aug 15; 16(6):651-60. PubMed ID: 9263127
    [Abstract] [Full Text] [Related]

  • 9. New potent cathepsin G phosphonate inhibitors.
    Sieńczyk M, Lesner A, Wysocka M, Legowska A, Pietrusewicz E, Rolka K, Oleksyszyn J.
    Bioorg Med Chem; 2008 Oct 01; 16(19):8863-7. PubMed ID: 18805698
    [Abstract] [Full Text] [Related]

  • 10. Potent and selective Kunitz domain inhibitors of plasma kallikrein designed by phage display.
    Dennis MS, Herzka A, Lazarus RA.
    J Biol Chem; 1995 Oct 27; 270(43):25411-7. PubMed ID: 7592708
    [Abstract] [Full Text] [Related]

  • 11. Heterologous expression of three plant serpins with distinct inhibitory specificities.
    Dahl SW, Rasmussen SK, Hejgaard J.
    J Biol Chem; 1996 Oct 11; 271(41):25083-8. PubMed ID: 8810262
    [Abstract] [Full Text] [Related]

  • 12. Semisynthetic aprotinin derivatives with specific alterations at the reactive-site peptide bond can be used to study structure-function relationships.
    Mehlich A, Beckmann J, Wenzel HR, Tschesche H.
    Biochim Biophys Acta; 1989 Jun 13; 996(1-2):23-9. PubMed ID: 2472174
    [Abstract] [Full Text] [Related]

  • 13. Aprotinin derivatives with chromophoric leaving groups can be used as highly selective active-site titrants for serine proteinases and permit the determination of kinetic constants of enzyme-inhibitor complexes.
    Mehlich A, Beckmann J, Wenzel HR, Tschesche H.
    Biochim Biophys Acta; 1988 Dec 02; 957(3):420-9. PubMed ID: 2461739
    [Abstract] [Full Text] [Related]

  • 14. Enhancement of chymotrypsin-inhibitor/substrate interactions by 3 M NaCl.
    Wesołowska O, Krokoszyńska I, Krowarsch D, Otlewski J.
    Biochim Biophys Acta; 2001 Feb 09; 1545(1-2):78-85. PubMed ID: 11342033
    [Abstract] [Full Text] [Related]

  • 15. Expression, purification, biochemical and pharmacological characterization of a recombinant aprotinin variant.
    Apeler H, Peters J, Schröder W, Schneider KH, Lemm G, Hinz V, Rossouw GJ, Dembowsky K.
    Arzneimittelforschung; 2004 Feb 09; 54(8):483-97. PubMed ID: 15460216
    [Abstract] [Full Text] [Related]

  • 16. Enzymatic semisynthesis of aprotinin homologues mutated in P' positions.
    Groeger C, Wenzel HR, Tschesche H.
    J Protein Chem; 1991 Apr 09; 10(2):245-51. PubMed ID: 1718310
    [Abstract] [Full Text] [Related]

  • 17. Primary structure and properties of the cathepsin G/chymotrypsin inhibitor from the larval hemolymph of Apis mellifera.
    Bania J, Stachowiak D, Polanowski A.
    Eur J Biochem; 1999 Jun 09; 262(3):680-7. PubMed ID: 10411628
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of serine proteinases plasmin, trypsin, subtilisin A, cathepsin G, and elastase by LEKTI: a kinetic analysis.
    Mitsudo K, Jayakumar A, Henderson Y, Frederick MJ, Kang Y, Wang M, El-Naggar AK, Clayman GL.
    Biochemistry; 2003 Apr 08; 42(13):3874-81. PubMed ID: 12667078
    [Abstract] [Full Text] [Related]

  • 19. An unexpected inhibitory activity of Kunitz-type serine proteinase inhibitor derived from Boophilus microplus trypsin inhibitor on cathepsin L.
    Sasaki SD, Cotrin SS, Carmona AK, Tanaka AS.
    Biochem Biophys Res Commun; 2006 Mar 03; 341(1):266-72. PubMed ID: 16414023
    [Abstract] [Full Text] [Related]

  • 20. Phage display selection of P1 mutants of BPTI directed against five different serine proteinases.
    Kiczak L, Koscielska K, Otlewski J, Czerwinski M, Dadlez M.
    Biol Chem; 1999 Jan 03; 380(1):101-5. PubMed ID: 10064144
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.